Technology, Product and RNA Production Partnering

Partnering is a key component of our corporate strategy. See our current strategic partnerships. eTheRNA is exploring innovative ideas – at all stages of development. eTheRNA focuses on maximizing the value of its mRNA platforms via three routes:

Technology Partnering
eTheRNA intends to build high-value strategic collaborations for exploring the benefits of the its various platform technologies in various disease areas.

eTheRNA seeks collaborative partnerships with pharma companies that enable us to develop - and ultimately also to commercialize - differentiated mRNA based immunotherapies on either a risk-sharing or out-licensing basis.

mRNA Production Partnering
eTheRNA operates a cGMP accredited mRNA production facility in Niel, Belgium and currently focusses on producing mRNA-constructs exclusively for its own development plans. However as the clinical development program advances, the Company has the option to expand capacity and explore strategic partnerships.